Advertisement

Renal Perfusion During Aortic Surgery: Looking for the Ideal Substrate

Curitiba Trial Investigators
  • Y. TshombaEmail author
  • E. Simonini
  • E. Colombo
  • V. Ardita
  • L. Apruzzi
  • E. Rinaldi
  • L. Pasin
  • T. Cambiaghi
  • B. Catenaccio
  • R. Castellano
  • M. Venturini
  • G. Landoni
  • P. Nardelli
  • M. Leopardi
  • E. Espinar
  • S. Salvati
  • R. Lembo
  • D. Baccellieri
  • L. Bertoglio
  • A. Kahlberg
  • S. Bossi
  • G. Melissano
  • Roberto Chiesa
Chapter

Abstract

Renal dysfunction is a common complication after open thoracoabdominal aortic aneurysm (TAAA) repair that is often associated with poor outcomes (Tang et al., BMC Nephrol 18:184, 2017).

In recent years, open TAAA repair morbidity and mortality have significantly decreased, mostly due to multimodal approaches based on distal aortic perfusion, together with several organ protection strategies (Wong et al., J Am Coll Surg 212:569–79, 2011).

Among the surgical adjuncts that have been developed to protect renal function, the direct perfusion of renal arteries plays a crucial role. Current consensus practice guidelines recommend either cold crystalloid or blood to be considered for renal perfusion during open TAAA repair (class IIb, level of evidence B) (Hiratzka et al., Circulation 121:e266–369, 2010). This confirms the value of reducing temperature in order to prolong kidney ischemic tolerance but leaves open the choice for the substrate to be used (Semb et al., Acta Chir Scand Suppl 253:196–202, 1960).

An organ protective solution should be effective due to its composition in addition to cooling. Until recent times, neither specific substrates nor infusion protocols were universally standardized. The result is that different solutions are now used across the world; however, lactated Ringer’s solution is the most common and is variably modified and customized according to individual practice more than to rigorous trials or evidence-based data.

Different agents could be carefully evaluated and compared to establish the best solutions available for kidney protection; among these, the off-label use of Custodiol solution for direct in vivo renal perfusion has been shown to be safe and effective, even with reduced acute kidney injury rates compared to lactated Ringer’s solution.

This chapter reports the state of the art of renal perfusion during aortic surgery and especially focuses on the rationale and results of the off-label use of Custodiol solution.

References

  1. 1.
    Tang Y, Chen J, Huang K, Luo D, Liang P, Feng M, Chai W, Fung E, Lan HY, Xu A. The incidence, risk factors and in-hospital mortality of acute kidney injury in patients after abdominal aortic aneurysm repair surgery. BMC Nephrol. 2017;18(1):184.CrossRefGoogle Scholar
  2. 2.
    Wong DR, Parenti JL, Green SY, Chowdhary V, Liao JM, Zarda S, et al. Open repair of thoracoabdominal aortic aneurysm in the modern surgical era: contemporary outcomes in 509 patients. J Am Coll Surg. 2011;212(4):569–79.CrossRefGoogle Scholar
  3. 3.
    Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American College of Radiology; American Stroke Association; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of Thoracic Surgeons; Society for Vascular Medicine, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121(13):e266–369.PubMedGoogle Scholar
  4. 4.
    Semb G, Krog J, Johansen K. Renal metabolism and blood flow during local hypothermia, studied by means of renal perfusion in situ. Acta Chir Scand Suppl. 1960;253:196–202.PubMedGoogle Scholar
  5. 5.
    Koletsky S. Effects of temporary interruption of renal circulation in rats. Arch Pathol. 1954;58:592.Google Scholar
  6. 6.
    Hamilton PB, Phillips RA, Hiller A. Duration of renal ischemia required to produce uraemia. Am J Phys. 1949;152:517.CrossRefGoogle Scholar
  7. 7.
    Badenoch AW, Darmady EM. Effects of temporary occlusion of the renal artery in rabbits and its relationship to traumatic uraemia. J Pathol Bacteriol. 1947;4:79.CrossRefGoogle Scholar
  8. 8.
    Parekh DJ, Weinberg JM, Ercole B, Torkko KC, Hilton W, Bennett M, Devarajan P, Venkatachalam MA. Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol. 2013;24(3):506–17.  https://doi.org/10.1681/ASN.2012080786.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Köksoy C, LeMaire SA, Curling PE, Raskin SA, Schmittling ZC, Conklin LD, et al. Renal perfusion during thoracoabdominal aortic operations: cold crystalloid is superior to normothermic blood. Ann Thorac Surg. 2002;73:730–8.CrossRefGoogle Scholar
  10. 10.
    Hassoun HT, Miller CC 3rd, Huynh TT, Estrera AL, Smith JJ, Safi HJ. Cold visceral perfusion improves early survival in patients with acute renal failure after thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2004;39(3):506–12.CrossRefGoogle Scholar
  11. 11.
    Lemaire SA, Jones MM, Conklin LD, Carter SA, Criddell MD, Wang XL, Raskin SA, Coselli JS. Randomized comparison of cold blood and cold crystalloid renal perfusion for renal protection during thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2009;49(1):11–9.CrossRefGoogle Scholar
  12. 12.
    Wynn MM, Acher C, Marks E, Engelbert T, Acher CW. Postoperative renal failure in thoracoabdominal aortic aneurysm repair with simple cross-clamp technique and 4°C renal perfusion. J Vasc Surg. 2015;61(3):611–22.  https://doi.org/10.1016/j.jvs.2014.10.040.CrossRefPubMedGoogle Scholar
  13. 13.
    Kalder J, Kokozidou M, Keschenau P, Tamm M, Greiner A, Koeppel TA, Tolba R, Jacobs MJ. Selective renal blood perfusion induces renal tubules injury in a porcine model. J Vasc Surg. 2016;63(3):778–87.CrossRefGoogle Scholar
  14. 14.
    Idu MM, Heintjes RJ, Scholten EW, Balm R, de Mol BA, Legemate DA. Visceral and renal tissue oxygenation during supraceliac aortic crossclamping and left heart bypass with selective organ perfusion. Eur J Vasc Endovasc Surg. 2004;27:138–44.CrossRefGoogle Scholar
  15. 15.
    Jacobs MJ, van Eps RG, de Jong DS, Schurink GW, Mochtar B. Prevention of renal failure in patients undergoing thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2004;40(6):1067–73.CrossRefGoogle Scholar
  16. 16.
    Jacobs MJ, van Eps RG, de Jong DS, Schurink GW, Mochtar B. Regarding “Prevention of renal failure in patients undergoing thoracoabdominal aortic aneurysm repair”. J Vasc Surg. 2006;43(2):428–9.PubMedGoogle Scholar
  17. 17.
    Viana FF, Shi WY, Hayward PA, Larobina ME, Liskaser F, Matalanis G. Custodiol versus blood cardioplegia in complex cardiac operations: an Australian experience. Eur J Cardiothorac Surg. 2013;43(3):526–31.CrossRefGoogle Scholar
  18. 18.
    Ounissi M, Cherif M, Abdallah TB, Bacha M, Hedri H, Abderrahim E, et al. Risk factors and consequences of delayed graft function. Saudi J Kidney Dis Transpl. 2013;24(2):243–6.CrossRefGoogle Scholar
  19. 19.
    O’Callaghan JM, Knight SR, Morgan RD, Morris PJ. Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant. 2012;12:896–906.CrossRefGoogle Scholar
  20. 20.
    Klaus F, Castro DB, Bittar CM, Bittar AE, Keitel E, Seelig DC, Goldani JC, Meinne MH, Garcia VD. Kidney transplantation with Belzer or Custodiol solution: a randomized prospective study. Transplant Proc. 2007;39(2):353–4.CrossRefGoogle Scholar
  21. 21.
    Gschwend JE, de Petriconi R, Maier S, Kleinschmidt K, Hautmann RE. Continuous in situ cold perfusion with histidine tryptophan ketoglutarate solution in nephron sparing surgery for renal tumors. J Urol. 1995;154(4):1307–11.CrossRefGoogle Scholar
  22. 22.
    Tshomba Y, Kahlberg A, Melissano G, Coppi G, Marone E, Ferrari D, Lembo R, Chiesa R. Comparison of renal perfusion solutions during thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2014;59(3):623–33.CrossRefGoogle Scholar
  23. 23.
    Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–83.CrossRefGoogle Scholar
  24. 24.
    Rauen U, Petrat F, Li T, De Groot H. Hypothermia injury/cold-induced apoptosis—evidence of an increase in chelatable iron causing oxidative injury in spite of low O2-/H2O2 formation. FASEB J. 2000;14(13):1953–64.CrossRefGoogle Scholar
  25. 25.
    Rauen U, Klempt S, de Groot H. Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators. Cell Mol Life Sci. 2007;64(2):192–205.CrossRefGoogle Scholar
  26. 26.
    Loganathan S, Radovits T, Hirschberg K, Korkmaz S, Koch A, Karck M, Szabó G. Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury. J Thorac Cardiovasc Surg. 2010;139(4):1048–56.CrossRefGoogle Scholar
  27. 27.
    Molitoris BA, Marrs J. The role of cell adhesion molecules in ischemic acute renal failure. Am J Med. 1999;106(5):583–92.CrossRefGoogle Scholar
  28. 28.
    Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996;97(4):1056–63.CrossRefGoogle Scholar
  29. 29.
    Salmela K, Wramner L, Ekberg H, Hauser I, Bentdal O, Lins LE, Isoniemi H, Bäckman L, Persson N, Neumayer HH, Jørgensen PF, Spieker C, Hendry B, Nicholls A, Kirste G, Hasche G. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation. 1999;67(5):729–36.CrossRefGoogle Scholar
  30. 30.
    Dehnadi A, Benedict Cosimi A, Neal Smith R, Li X, Alonso JL, Means TK, Arnaout MA. Prophylactic orthosteric inhibition of leukocyte integrin CD11b/CD18 prevents long-term fibrotic kidney failure in cynomolgus monkeys. Nat Commun. 2017;8:13899.CrossRefGoogle Scholar
  31. 31.
    Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34:1913–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Y. Tshomba
    • 1
    • 2
    Email author
  • E. Simonini
    • 5
  • E. Colombo
    • 5
  • V. Ardita
    • 5
  • L. Apruzzi
    • 5
  • E. Rinaldi
    • 5
  • L. Pasin
    • 7
  • T. Cambiaghi
    • 5
  • B. Catenaccio
    • 5
  • R. Castellano
    • 5
  • M. Venturini
    • 8
  • G. Landoni
    • 9
    • 10
  • P. Nardelli
    • 7
  • M. Leopardi
    • 5
  • E. Espinar
    • 5
  • S. Salvati
    • 5
  • R. Lembo
    • 7
  • D. Baccellieri
    • 6
  • L. Bertoglio
    • 5
  • A. Kahlberg
    • 3
    • 4
  • S. Bossi
    • 5
  • G. Melissano
    • 3
    • 4
  • Roberto Chiesa
    • 11
  1. 1.Unit of Vascular SurgeryFondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro CuoreRomeItaly
  2. 2.Unit of Vascular SurgerySan Raffaele Scientific Institute, Vita-Salute UniversityMilanItaly
  3. 3.Vascular Surgery UnitIRCCS San Raffaele Scientific InstituteMilanItaly
  4. 4.Vita-Salute San Raffaele University of MilanMilanItaly
  5. 5.Vascular Surgery UnitIRCCS San Raffaele Scientific InstituteMilanItaly
  6. 6.Unit of Vascular SurgerySan Raffaele Scientific InstituteMilanItaly
  7. 7.Department of Anesthesia and Intensive CareIRCCS San Raffaele Scientific InstituteMilanItaly
  8. 8.Department of RadiologyIRCCS San Raffaele Scientific InstituteMilanItaly
  9. 9.Vita-Salute San Raffaele University of MilanMilanItaly
  10. 10.Department of Anesthesia and Intensive CareIRCCS San Raffaele Scientific InstituteMilanItaly
  11. 11.Unit of Vascular SurgerySan Raffaele Scientific Institute, Vita-Salute UniversityMilanItaly

Personalised recommendations